Literature DB >> 21573591

Multiple pathway drug-resistance (review).

J Mattern, M Volm.   

Abstract

During the past few years it has become apparent that multiple mechanisms of resistance are playing a role in the clinical manifestations of drug resistance. In different organs and tumors, various components of the resistance phenotype are expressed to varying degrees. The cells utilize multiple pathways to overcome the cytotoxic effects of chemotherapeutic agents. No single mechanism can account for the full extent of resistance.

Entities:  

Year:  1993        PMID: 21573591     DOI: 10.3892/ijo.2.4.557

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Antioxidant and glutathione-associated enzymes in Wilms' tumour after chemotherapy.

Authors:  J Gajewska; M Szczypka; T Izbicki; T Klepacka; T Laskowska-Klita
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

3.  Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.

Authors:  A Dimitrakopoulou-Strauss; L G Strauss; H Goldschmidt; W J Lorenz; W Maier-Borst; G van Kaick
Journal:  Eur J Nucl Med       Date:  1995-05

4.  Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.

Authors:  V Gekeler; J Beck; A Noller; A Wilisch; G Frese; M Neumann; R Handgretinger; G Ehninger; H Probst; D Niethammer
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

Review 5.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.